Get started
RocketTickers

FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPL

Long
Intra-Cellular Therapies Inc. (NASDAQ:ITCI)  
RocketTickers  
NASDAQ:ITCI   Intra-Cellular Therapies Inc.
Beyond Technical Analysis
1
0
beyondta
ITCI: Intra-Cellular Therapies Inc.
2019-12-23 06:59:10
FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in Adults
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.